ALTEOGEN revenue and financials
₩259,500.00Change from previous close: −2.08%Absolute change: −₩5,500.00
In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +109.87%
- 2025 vs 2024
- Net income growth
- +127.57%
- 2025 vs 2024
- Net margin
- 65.6%
- 2024: 60.5%
Financial data
Amounts in millions of KRW; per-share values in KRW; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 68,894 | 71,599 | 64,507 | 49,013 | 18,643 | — |
| Cost of revenue | 7,395 | 10,069 | 21,934 | 9,152 | 6,577 | — |
| Gross profit | 61,499 | 61,530 | 42,573 | 39,861 | 12,066 | — |
| Selling, general and administrative | 2,230 | 3,108 | 2,041 | 1,315 | 1,026 | — |
| Research and development | 20,741 | 15,389 | 14,912 | 7,959 | 8,205 | — |
| Operating income | 34,180 | 39,301 | 19,638 | 26,671 | -426 | — |
| EBIT | 36,696 | 86,790 | 72,757 | 33,431 | 4,208 | — |
| EBITDA | 36,990 | 89,688 | 75,558 | 34,308 | 4,425 | — |
| Interest expense | 3,946 | 3,107 | 3,488 | 3,073 | 3,095 | — |
| Pre-tax income | 32,749 | 83,684 | 69,268 | 30,359 | 1,113 | — |
| Income tax | 2,761 | 12,339 | -5,159 | 8,334 | 35,431 | — |
| Net income | 28,419 | 71,697 | 69,238 | 22,345 | -33,094 | — |
| Net income to common shareholders | 28,419 | 71,697 | 69,238 | 22,345 | -33,094 | — |
| Basic EPS | 408.46 | 1,030.77 | — | 321.54 | -476.92 | 1,200.77 |
| Diluted EPS | 408.46 | 702.31 | — | 194.62 | -599.23 | 1,194.62 |
| Average shares (basic) | 69.6 | 69.5 | — | 69.5 | 69.4 | 69.3 |
| Average shares (diluted) | 69.6 | 70.2 | — | 70.4 | 55.2 | 69.6 |